Haemonetics Corporation
HAE
$70.09
-$1.27-1.78%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 42.64% | 2.76% | -3.48% | -15.87% | 1.87% |
| Total Depreciation and Amortization | 22.88% | 25.30% | 18.78% | 10.82% | 4.49% |
| Total Amortization of Deferred Charges | -22.09% | -8.24% | -15.33% | -11.09% | -17.86% |
| Total Other Non-Cash Items | -98.99% | -73.97% | -66.85% | -42.33% | 13.02% |
| Change in Net Operating Assets | -36.49% | -64.17% | -883.77% | -411.10% | -392.91% |
| Cash from Operations | -0.01% | -34.48% | -67.61% | -45.94% | -33.44% |
| Capital Expenditure | -3.02% | 30.07% | 59.34% | 48.47% | 65.40% |
| Sale of Property, Plant, and Equipment | 1,184.70% | 542.27% | 528.12% | 1,339.81% | 12.56% |
| Cash Acquisitions | 38.12% | 38.12% | -- | -- | -8,456.21% |
| Divestitures | 2,786.07% | -- | -- | 76.47% | 76.47% |
| Other Investing Activities | 12.50% | 1.93% | -75.64% | -32.81% | -31.67% |
| Cash from Investing | 49.78% | 41.04% | -368.44% | -342.63% | -124.21% |
| Total Debt Issued | 763.64% | 763.64% | -- | 221.21% | -66.67% |
| Total Debt Repaid | -595.76% | -5,277.38% | -864.36% | -95.33% | 78.73% |
| Issuance of Common Stock | 15.51% | 14.20% | 19.43% | 2.40% | 2.82% |
| Repurchase of Common Stock | -3,897.33% | -1,348.48% | -1,352.19% | 81.50% | 92.15% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12,002.39% | -13,418.77% | -12,437.91% | -1,055.86% | 95.95% |
| Cash from Financing | 185.18% | 96.66% | 616.17% | 580.16% | 138.02% |
| Foreign Exchange rate Adjustments | 78.49% | -27,881.82% | 101.90% | -171.57% | 19.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 221.10% | 522.56% | -147.10% | -17.04% | -523.17% |